nodes	percent_of_prediction	percent_of_DWPC	metapath
Piperacillin—Cefaclor—MPO—chronic obstructive pulmonary disease	0.00603	0.348	CrCbGaD
Piperacillin—Nafcillin—CYP1A2—chronic obstructive pulmonary disease	0.00419	0.241	CrCbGaD
Piperacillin—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00376	0.00383	CcSEcCtD
Piperacillin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00375	0.00382	CcSEcCtD
Piperacillin—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00372	0.00378	CcSEcCtD
Piperacillin—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.0037	0.00376	CcSEcCtD
Piperacillin—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00366	0.00372	CcSEcCtD
Piperacillin—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00365	0.00372	CcSEcCtD
Piperacillin—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00363	0.00369	CcSEcCtD
Piperacillin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00363	0.00369	CcSEcCtD
Piperacillin—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00363	0.00369	CcSEcCtD
Piperacillin—Shock—Aminophylline—chronic obstructive pulmonary disease	0.0036	0.00366	CcSEcCtD
Piperacillin—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.0036	0.00366	CcSEcCtD
Piperacillin—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.0036	0.00366	CcSEcCtD
Piperacillin—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00359	0.00365	CcSEcCtD
Piperacillin—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00357	0.00364	CcSEcCtD
Piperacillin—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.00354	0.00361	CcSEcCtD
Piperacillin—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00354	0.0036	CcSEcCtD
Piperacillin—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00354	0.0036	CcSEcCtD
Piperacillin—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00352	0.00358	CcSEcCtD
Piperacillin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00349	0.00355	CcSEcCtD
Piperacillin—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00347	0.00353	CcSEcCtD
Piperacillin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00346	0.00352	CcSEcCtD
Piperacillin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00345	0.00352	CcSEcCtD
Piperacillin—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00345	0.00351	CcSEcCtD
Piperacillin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00344	0.0035	CcSEcCtD
Piperacillin—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00343	0.00349	CcSEcCtD
Piperacillin—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00342	0.00348	CcSEcCtD
Piperacillin—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00341	0.00347	CcSEcCtD
Piperacillin—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00341	0.00347	CcSEcCtD
Piperacillin—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00339	0.00345	CcSEcCtD
Piperacillin—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00338	0.00344	CcSEcCtD
Piperacillin—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00336	0.00342	CcSEcCtD
Piperacillin—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00335	0.00341	CcSEcCtD
Piperacillin—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00334	0.0034	CcSEcCtD
Piperacillin—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00332	0.00338	CcSEcCtD
Piperacillin—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00331	0.00337	CcSEcCtD
Piperacillin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00326	0.00332	CcSEcCtD
Piperacillin—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00322	0.00328	CcSEcCtD
Piperacillin—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00322	0.00328	CcSEcCtD
Piperacillin—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.00321	0.00327	CcSEcCtD
Piperacillin—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00317	0.00323	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00314	0.0032	CcSEcCtD
Piperacillin—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00312	0.00317	CcSEcCtD
Piperacillin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00304	0.00309	CcSEcCtD
Piperacillin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00299	0.00304	CcSEcCtD
Piperacillin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00295	0.003	CcSEcCtD
Piperacillin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00291	0.00296	CcSEcCtD
Piperacillin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.0029	0.00296	CcSEcCtD
Piperacillin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.0029	0.00296	CcSEcCtD
Piperacillin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.0029	0.00296	CcSEcCtD
Piperacillin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.0029	0.00296	CcSEcCtD
Piperacillin—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00289	0.00295	CcSEcCtD
Piperacillin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00289	0.00294	CcSEcCtD
Piperacillin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00289	0.00294	CcSEcCtD
Piperacillin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00288	0.00293	CcSEcCtD
Piperacillin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00288	0.00293	CcSEcCtD
Piperacillin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00284	0.00289	CcSEcCtD
Piperacillin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00284	0.00289	CcSEcCtD
Piperacillin—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00284	0.00289	CcSEcCtD
Piperacillin—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00284	0.00289	CcSEcCtD
Piperacillin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00282	0.00287	CcSEcCtD
Piperacillin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00282	0.00287	CcSEcCtD
Piperacillin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00278	0.00283	CcSEcCtD
Piperacillin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00278	0.00283	CcSEcCtD
Piperacillin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00278	0.00283	CcSEcCtD
Piperacillin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00278	0.00283	CcSEcCtD
Piperacillin—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.00278	0.00283	CcSEcCtD
Piperacillin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00274	0.00279	CcSEcCtD
Piperacillin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00274	0.00279	CcSEcCtD
Piperacillin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00274	0.00279	CcSEcCtD
Piperacillin—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00273	0.00278	CcSEcCtD
Piperacillin—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00273	0.00278	CcSEcCtD
Piperacillin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00273	0.00277	CcSEcCtD
Piperacillin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00273	0.00277	CcSEcCtD
Piperacillin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00273	0.00277	CcSEcCtD
Piperacillin—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00271	0.00275	CcSEcCtD
Piperacillin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.0027	0.00275	CcSEcCtD
Piperacillin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.0027	0.00275	CcSEcCtD
Piperacillin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00269	0.00274	CcSEcCtD
Piperacillin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00268	0.00273	CcSEcCtD
Piperacillin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00267	0.00272	CcSEcCtD
Piperacillin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00267	0.00272	CcSEcCtD
Piperacillin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00265	0.0027	CcSEcCtD
Piperacillin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00263	0.00267	CcSEcCtD
Piperacillin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00263	0.00267	CcSEcCtD
Piperacillin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.0026	0.00265	CcSEcCtD
Piperacillin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.0026	0.00265	CcSEcCtD
Piperacillin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00259	0.00263	CcSEcCtD
Piperacillin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00259	0.00263	CcSEcCtD
Piperacillin—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00258	0.00263	CcSEcCtD
Piperacillin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00258	0.00262	CcSEcCtD
Piperacillin—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00257	0.00262	CcSEcCtD
Piperacillin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00255	0.0026	CcSEcCtD
Piperacillin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00254	0.00259	CcSEcCtD
Piperacillin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00254	0.00259	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00254	0.00258	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00254	0.00258	CcSEcCtD
Piperacillin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00252	0.00256	CcSEcCtD
Piperacillin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00252	0.00256	CcSEcCtD
Piperacillin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.0025	0.00255	CcSEcCtD
Piperacillin—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.00249	0.00254	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00248	0.00253	CcSEcCtD
Piperacillin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00247	0.00251	CcSEcCtD
Piperacillin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00246	0.0025	CcSEcCtD
Piperacillin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00245	0.00249	CcSEcCtD
Piperacillin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00245	0.00249	CcSEcCtD
Piperacillin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00244	0.00248	CcSEcCtD
Piperacillin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00242	0.00246	CcSEcCtD
Piperacillin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.0024	0.00244	CcSEcCtD
Piperacillin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.0024	0.00244	CcSEcCtD
Piperacillin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.0024	0.00244	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00239	0.00244	CcSEcCtD
Piperacillin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00238	0.00242	CcSEcCtD
Piperacillin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00238	0.00242	CcSEcCtD
Piperacillin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00238	0.00242	CcSEcCtD
Piperacillin—Pain—Formoterol—chronic obstructive pulmonary disease	0.00238	0.00242	CcSEcCtD
Piperacillin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00238	0.00242	CcSEcCtD
Piperacillin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00235	0.00239	CcSEcCtD
Piperacillin—Pain—Montelukast—chronic obstructive pulmonary disease	0.00233	0.00237	CcSEcCtD
Piperacillin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00233	0.00237	CcSEcCtD
Piperacillin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00231	0.00235	CcSEcCtD
Piperacillin—Purpura—Prednisone—chronic obstructive pulmonary disease	0.00231	0.00235	CcSEcCtD
Piperacillin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00231	0.00235	CcSEcCtD
Piperacillin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.0023	0.00234	CcSEcCtD
Piperacillin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00229	0.00233	CcSEcCtD
Piperacillin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00228	0.00232	CcSEcCtD
Piperacillin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00228	0.00232	CcSEcCtD
Piperacillin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00228	0.00232	CcSEcCtD
Piperacillin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00227	0.00231	CcSEcCtD
Piperacillin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00225	0.00229	CcSEcCtD
Piperacillin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00225	0.00229	CcSEcCtD
Piperacillin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00223	0.00227	CcSEcCtD
Piperacillin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00221	0.00225	CcSEcCtD
Piperacillin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00221	0.00225	CcSEcCtD
Piperacillin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.0022	0.00224	CcSEcCtD
Piperacillin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.0022	0.00224	CcSEcCtD
Piperacillin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.0022	0.00224	CcSEcCtD
Piperacillin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.0022	0.00224	CcSEcCtD
Piperacillin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00219	0.00223	CcSEcCtD
Piperacillin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00217	0.00221	CcSEcCtD
Piperacillin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00217	0.00221	CcSEcCtD
Piperacillin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00217	0.00221	CcSEcCtD
Piperacillin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00217	0.0022	CcSEcCtD
Piperacillin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00216	0.0022	CcSEcCtD
Piperacillin—Cloxacillin—ALB—chronic obstructive pulmonary disease	0.00216	0.124	CrCbGaD
Piperacillin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00216	0.00219	CcSEcCtD
Piperacillin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00216	0.00219	CcSEcCtD
Piperacillin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00215	0.00219	CcSEcCtD
Piperacillin—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00213	0.00217	CcSEcCtD
Piperacillin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00212	0.00216	CcSEcCtD
Piperacillin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00209	0.00212	CcSEcCtD
Piperacillin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00208	0.00211	CcSEcCtD
Piperacillin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00208	0.00211	CcSEcCtD
Piperacillin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00205	0.00209	CcSEcCtD
Piperacillin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00205	0.00209	CcSEcCtD
Piperacillin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00205	0.00208	CcSEcCtD
Piperacillin—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00203	0.00206	CcSEcCtD
Piperacillin—Cefoperazone—ALB—chronic obstructive pulmonary disease	0.00202	0.116	CrCbGaD
Piperacillin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00201	0.00204	CcSEcCtD
Piperacillin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.002	0.00203	CcSEcCtD
Piperacillin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.002	0.00203	CcSEcCtD
Piperacillin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00197	0.002	CcSEcCtD
Piperacillin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00197	0.002	CcSEcCtD
Piperacillin—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.00197	0.002	CcSEcCtD
Piperacillin—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00197	0.002	CcSEcCtD
Piperacillin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00196	0.00199	CcSEcCtD
Piperacillin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00194	0.00197	CcSEcCtD
Piperacillin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00193	0.00196	CcSEcCtD
Piperacillin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.0019	0.00194	CcSEcCtD
Piperacillin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.0019	0.00194	CcSEcCtD
Piperacillin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00189	0.00192	CcSEcCtD
Piperacillin—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00188	0.00191	CcSEcCtD
Piperacillin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00187	0.0019	CcSEcCtD
Piperacillin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00186	0.00189	CcSEcCtD
Piperacillin—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00185	0.00188	CcSEcCtD
Piperacillin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00184	0.00187	CcSEcCtD
Piperacillin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00184	0.00187	CcSEcCtD
Piperacillin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.0018	0.00183	CcSEcCtD
Piperacillin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.0018	0.00183	CcSEcCtD
Piperacillin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.00183	CcSEcCtD
Piperacillin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.0018	CcSEcCtD
Piperacillin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00177	0.0018	CcSEcCtD
Piperacillin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00176	0.00179	CcSEcCtD
Piperacillin—Rash—Formoterol—chronic obstructive pulmonary disease	0.00176	0.00179	CcSEcCtD
Piperacillin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00175	0.00178	CcSEcCtD
Piperacillin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00175	0.00178	CcSEcCtD
Piperacillin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00174	0.00177	CcSEcCtD
Piperacillin—Headache—Formoterol—chronic obstructive pulmonary disease	0.00174	0.00177	CcSEcCtD
Piperacillin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00174	0.00177	CcSEcCtD
Piperacillin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00173	0.00176	CcSEcCtD
Piperacillin—Rash—Montelukast—chronic obstructive pulmonary disease	0.00172	0.00175	CcSEcCtD
Piperacillin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00172	0.00175	CcSEcCtD
Piperacillin—Ampicillin—ALB—chronic obstructive pulmonary disease	0.00171	0.0987	CrCbGaD
Piperacillin—Headache—Montelukast—chronic obstructive pulmonary disease	0.00171	0.00174	CcSEcCtD
Piperacillin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.0017	CcSEcCtD
Piperacillin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00166	0.00169	CcSEcCtD
Piperacillin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00166	0.00168	CcSEcCtD
Piperacillin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00165	0.00168	CcSEcCtD
Piperacillin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00165	0.00168	CcSEcCtD
Piperacillin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00165	0.00168	CcSEcCtD
Piperacillin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00162	0.00165	CcSEcCtD
Piperacillin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.0016	0.00163	CcSEcCtD
Piperacillin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00159	CcSEcCtD
Piperacillin—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00155	0.00158	CcSEcCtD
Piperacillin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00154	0.00157	CcSEcCtD
Piperacillin—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00153	0.00156	CcSEcCtD
Piperacillin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00151	0.00153	CcSEcCtD
Piperacillin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00151	0.00153	CcSEcCtD
Piperacillin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00148	0.00151	CcSEcCtD
Piperacillin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00146	0.00148	CcSEcCtD
Piperacillin—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00143	0.00146	CcSEcCtD
Piperacillin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.0014	0.00142	CcSEcCtD
Piperacillin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.00139	0.00142	CcSEcCtD
Piperacillin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00136	0.00139	CcSEcCtD
Piperacillin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00134	0.00137	CcSEcCtD
Piperacillin—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00134	0.00137	CcSEcCtD
Piperacillin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00129	0.00131	CcSEcCtD
Piperacillin—Cephalexin—ALB—chronic obstructive pulmonary disease	0.00125	0.072	CrCbGaD
Piperacillin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00124	0.00126	CcSEcCtD
Piperacillin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.0012	0.00122	CcSEcCtD
Piperacillin—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00118	CcSEcCtD
Piperacillin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00116	CcSEcCtD
Piperacillin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00116	CcSEcCtD
Piperacillin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00113	0.00115	CcSEcCtD
Piperacillin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00113	CcSEcCtD
Piperacillin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00111	CcSEcCtD
Piperacillin—Oedema—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00111	CcSEcCtD
Piperacillin—Shock—Prednisone—chronic obstructive pulmonary disease	0.00108	0.0011	CcSEcCtD
Piperacillin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00109	CcSEcCtD
Piperacillin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00108	CcSEcCtD
Piperacillin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00108	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000998	0.00102	CcSEcCtD
Piperacillin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000997	0.00101	CcSEcCtD
Piperacillin—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000991	0.00101	CcSEcCtD
Piperacillin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000964	0.000981	CcSEcCtD
Piperacillin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000951	0.000967	CcSEcCtD
Piperacillin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00095	0.000966	CcSEcCtD
Piperacillin—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000944	0.000961	CcSEcCtD
Piperacillin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000944	0.000961	CcSEcCtD
Piperacillin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000937	0.000953	CcSEcCtD
Piperacillin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000896	0.000912	CcSEcCtD
Piperacillin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000895	0.000911	CcSEcCtD
Piperacillin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00087	0.000886	CcSEcCtD
Piperacillin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000866	0.000881	CcSEcCtD
Piperacillin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000866	0.000881	CcSEcCtD
Piperacillin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000807	0.000821	CcSEcCtD
Piperacillin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000786	0.0008	CcSEcCtD
Piperacillin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000775	0.000789	CcSEcCtD
Piperacillin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00075	0.000763	CcSEcCtD
Piperacillin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000724	0.000737	CcSEcCtD
Piperacillin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000697	0.000709	CcSEcCtD
Piperacillin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000691	0.000703	CcSEcCtD
Piperacillin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00069	0.000702	CcSEcCtD
Piperacillin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000686	0.000698	CcSEcCtD
Piperacillin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000651	0.000662	CcSEcCtD
